Sales rise 66.34% to Rs 21.84 crore
Net profit of Bafna Pharmaceuticals reported to Rs 2.64 crore in the quarter ended March 2021 as against net loss of Rs 0.16 crore during the previous quarter ended March 2020. Sales rose 66.34% to Rs 21.84 crore in the quarter ended March 2021 as against Rs 13.13 crore during the previous quarter ended March 2020.For the full year,net profit reported to Rs 5.83 crore in the year ended March 2021 as against net loss of Rs 25.20 crore during the previous year ended March 2020. Sales rose 67.69% to Rs 71.22 crore in the year ended March 2021 as against Rs 42.47 crore during the previous year ended March 2020.
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales21.8413.13 66 71.2242.47 68 OPM %19.2832.37 -14.462.92 - PBDT4.143.55 17 10.311.40 636 PBT2.643.03 -13 5.83-1.87 LP NP2.64-0.16 LP 5.83-25.20 LP
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
